SQI Diagnostics Inc.
SQIDF · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | 2.17 | 0.28 | 0.13 |
| FCF Yield | -27.28% | -15.97% | -10.29% | -25.97% |
| EV / EBITDA | -5.51 | -7.20 | -10.14 | -3.24 |
| Quality | ||||
| ROIC | -302.55% | -152.24% | -111.77% | -149.94% |
| Gross Margin | 38.30% | 83.64% | 77.32% | 67.85% |
| Cash Conversion Ratio | 0.53 | 0.82 | 0.81 | 0.70 |
| Growth | ||||
| Revenue 3-Year CAGR | 99.33% | -21.44% | -8.49% | 25.01% |
| Free Cash Flow Growth | -7.26% | -43.92% | -22.44% | 16.05% |
| Safety | ||||
| Net Debt / EBITDA | -1.49 | -0.27 | -0.35 | 0.03 |
| Interest Coverage | -7.52 | -19.38 | -11.62 | -11.23 |
| Efficiency | ||||
| Inventory Turnover | 4.02 | 0.17 | 0.64 | 0.86 |
| Cash Conversion Cycle | -117.08 | -3,753.73 | -894.92 | -237.95 |